Figure 2From: Dose selection method for pharmacokinetic study in hemodialysis patients using a subpharmacological dose: oseltamivir as a model drug Predicted AUC last of plasma oseltamivir carboxylate following continuous doses simulated from the low dose data with a nonparametric superposition method. The solid and dotted lines represent the fitted line and standard error, respectively. OC, oseltamivir carboxylate.Back to article page